Bishop Hans Edgar
SEC CIK 1480212 · EDGAR
Most active insiders at SANA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, CSO | — | — |
| 2 | Harr Steve | Pres, CEO, Dir | — | — |
| 3 | Wyrick Susan D. | See Remarks | — | — |
| 4 | Bishop Hans Edgar | Dir | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-07 16:31 | 2026-07-06 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +6,297 | 5.85M | +0.1% | $0 | |
| 2026-04-08 16:16 | 2026-04-06 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +7,763 | 5.85M | +0.1% | $0 | |
| 2026-01-06 | 2026-01-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +6,157 | 5.84M | +0.1% | $0 | |
| 2025-10-07 | 2025-10-06 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +5,628 | 5.83M | +0.1% | $0 | |
| 2025-07-08 | 2025-07-07 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +7,842 | 5.83M | +0.1% | $0 | |
| 2025-04-08 | 2025-04-07 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +16.3K | 5.82M | +0.3% | $0 | |
| 2025-01-07 | 2025-01-06 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +14.3K | 5.80M | +0.2% | $0 | |
| 2024-10-09 | 2024-10-07 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +5,938 | 5.79M | +0.1% | $0 | |
| 2024-07-08 | 2024-07-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +4,911 | 5.78M | +0.1% | $0 | |
| 2024-04-08 | 2024-04-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +2,774 | 5.78M | +0.0% | $0 | |
| M | 2024-03-19 | 2024-03-15 | A | Agilent Technologies | Bishop Hans Edgar | Dir | A - Grant | $147.48 | +2,428 | 25.0K | +11% | +$358.1K |
| 2024-01-08 | 2024-01-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +4,901 | 5.78M | +0.1% | $0 | |
| 2023-10-06 | 2023-10-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +6,925 | 5.77M | +0.1% | $0 | |
| 2023-07-06 | 2023-07-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +4,152 | 5.77M | +0.1% | $0 | |
| 2023-04-06 | 2023-04-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +7,716 | 5.76M | +0.1% | $0 | |
| M | 2023-03-20 | 2023-03-16 | A | Agilent Technologies | Bishop Hans Edgar | Dir | A - Grant | $136.82 | +2,399 | 22.4K | +12% | +$328.2K |
| 2023-01-06 | 2023-01-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +6,702 | 5.75M | +0.1% | $0 | |
| 2022-10-06 | 2022-10-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +4,012 | 5.75M | +0.1% | $0 | |
| D | 2022-09-09 | 2022-09-08 | LYEL | Lyell Immunopharma, Inc. | Bishop Hans Edgar | Dir | M - OptEx | $0.1 | +145.4K | 4.69M | +3% | +$14.5K |
| 2022-07-07 | 2022-07-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +3,328 | 5.74M | +0.1% | $0 | |
| 2022-04-06 | 2022-04-05 | SANA | Sana Biotechnology, Inc. | Bishop Hans Edgar | Dir | A - Grant | $0.00 | +2,880 | 5.74M | +0.1% | $0 | |
| M | 2022-03-21 | 2022-03-17 | A | Agilent Technologies | Bishop Hans Edgar | Dir | A - Grant | $136.82 | +2,582 | 19.1K | +16% | +$353.3K |
| D | 2022-02-25 | 2022-02-23 | LYEL | Lyell Immunopharma, Inc. | Bishop Hans Edgar | Dir | M - OptEx | $0.1 | +993.4K | 4.54M | +28% | +$99.3K |
Purchase Sale Sale after option exercise All abbreviations